Collectively, these findings suggest that HDAC6 interacts with poly (GA) and potentiates poly (GA) aggregation, and further indicate that strategies to reduce HDAC6 expression may represent a novel therapeutic avenue for c9FTD/ALS. This evidence concerns the gene HDAC6 and amyotrophic lateral sclerosis.